Diabetic Macular Edema

>

Latest News

4D Molecular Therapeutics: FDA clears IND application for 4D-150 genetic medicine to treat DME
4D Molecular Therapeutics: FDA clears IND application for 4D-150 genetic medicine to treat DME

February 3rd 2023

The Phase 2 SPECTRA clinical trial will assess 4D-150 in patients with DME.

Study: More than a quarter of older Americans have visual impairment
Study: More than a quarter of older Americans have visual impairment

January 17th 2023

Rezolute announces initiation of a phase 2 study of RZ402 in patients with diabetic macular edema
Rezolute announces initiation of a phase 2 study of RZ402 in patients with diabetic macular edema

December 19th 2022

2023: What awaits ophthalmology in the year ahead
2023: What awaits ophthalmology in the year ahead

December 12th 2022

Treating AMD and DME with faricimab: A therapy with lower treatment burden
Treating AMD and DME with faricimab: A therapy with lower treatment burden

December 2nd 2022

Video Series
Video Interviews

More News

© 2023 MJH Life Sciences

All rights reserved.